Ayala Pharmaceuticals Inc (fka ADXS)

[$5.95akadawson-m]

Almost every 2 days he talks about it. Just look it up.

On another topic germane to this discussion. I want to say that the science is sound - the latest info comes from two scientists who have dealt with Advaxis immunotherapy and validate its performance:

Q4. What is your vision for the future regarding this specific drug and immunotherapy in general?

R4. Most cervical cancers are caused by high-risk HPV, and have E6 and E7 oncogenes that are constitutively expressed, tumor-specific, and functionally important. That means cervical cancer can be attacked by different immunotherapy approaches more successfully than other gynecological cancers. We think that, along with ADXS-11, immunotherapy will play a big part in treating cervical cancer—mirroring the success of HPV vaccines in preventing cervical cancer.